FDA announcement about Losartan

30 Nov, -0001

Torrent Pharmaceuticals Ltd is expanding its voluntary recall from 10 lots of Losartan potassium tablets USP to include 6 lots of Losartan potassium and hydrochlorothiazide tablets, USP, to the consumer level due to the detection of trace amounts N-nitrosodiethylamine (NDEA), which has been classified as a probable human carcinogen. The list of losartan medications under recall was also updated (List).